Evaluation of Salmonella Gallinarum ghost formulated with Montanide™ ISA 70 VG adjuvant as a vaccine against fowl typhoid by Jawale, Chetan et al.
Acta Veterinaria Hungarica 63 (4), pp. 401–412 (2015) 
DOI: 10.1556/004.2015.038 
 
0236-6290/$ 20.00 © 2015 Akadémiai Kiadó, Budapest 
EVALUATION OF SALMONELLA GALLINARUM GHOST 
FORMULATED WITH MONTANIDETM ISA 70 VG ADJUVANT 
AS A VACCINE AGAINST FOWL TYPHOID 
Chetan V. JAWALE, Nithiphonh SOMSANITH, Seong Kug EO, Sang-Youel PARK  
and John Hwa LEE* 
Department of Bioactive Material Sciences, and Department of Veterinary Public Health, 
College of Veterinary Medicine, Chonbuk National University, Jeonju 561-756, Korea 
(Received 2 February 2015; accepted 22 June 2015) 
Escherichia coli heat-labile enterotoxin B subunit (LTB) protein is a po-
tent adjuvant. Salmonella Gallinarum ghosts carrying LTB (S. Gallinarum-LTB 
ghosts) were genetically constructed using a plasmid, pJHL187-LTB, designed 
for the co-expression of the LTB and E lysis proteins. This study evaluates the 
immunopotentiating effects of MontanideTM ISA 70 VG on S. Gallinarum-LTB 
ghost vaccination against fowl typhoid. Five-week-old layer chickens were in-
jected intramuscularly with sterile PBS (non-immunised control, Group A), S. 
Gallinarum-LTB ghost (Group B) or S. Gallinarum-LTB ghost emulsified with 
MontanideTM ISA 70 VG adjuvant (Group C). Chickens from both Groups B and 
C showed significant induction of antigen-specific systemic IgG response com-
pared to controls; in addition, Group C showed enhanced induction of systemic 
IgG response compared to Group B. We observed significant induction of anti-
gen-specific lymphocyte proliferative response and increased mRNA levels of 
Th1 cytokines (IFN-γ and IL2) in both Groups B and C. Furthermore, in the chal-
lenge experiment with a virulent strain of S. Gallinarum, Group C showed higher 
survival rates compared with other groups. These results indicate that vaccination 
with the S. Gallinarum-LTB ghost in combination with MontanideTM ISA 70 VG 
may enhance the protective immunity against fowl typhoid.  
Key words: Fowl typhoid, bacterial ghost, MontanideTM adjuvant, immu-
nity, protection 
Fowl typhoid (FT) is a septicaemic disease of domestic birds caused by 
the Gram-negative intracellular bacterial pathogen, Salmonella enterica serovar 
Gallinarum (Pomeroy and Nagaraja, 1991). Vaccination is the most effective and 
practical intervention for the eradication of fowl typhoid and lacks the risks and 
challenges associated with other control measures. Various vaccines to prevent 
fowl typhoid have been tested in fowl models (Bouzoubaa et al., 1989; Zhang-
Barber et al., 1998; Rosu et al., 2007; Chaudhari et al., 2011; Desin et al., 2013). 
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Bacterial ghosts are generated by temperature-controlled expression of the 
lysis E gene of bacteriophage PhiX174, which forms transmembrane holes 
through the bacterial cellular envelope, cloned in Gram-negative bacteria (Witte 
et al., 1992). More recently, we have demonstrated the vaccine potential of S. 
Gallinarum ghosts for protection against fowl typhoid (Chaudhari et al., 2012; 
Jawale and Lee, 2014b). The vaccine construction strategy incorporates a foreign 
immunomodulator protein such as Escherichia coli heat-labile enterotoxin B 
subunit (LTB) into the architecture of the ghost membrane, which may improve 
the immunogenic potential of the vaccine (Jawale and Lee, 2014a). 
Although bacterial ghosts possess conserved surface antigenic structures 
and are capable of inducing humoral and cell-mediated immune responses, their 
nonreplicating nature may be responsible for the rapid destruction and elimina-
tion of antigens from the host (Desin et al., 2013). The combination of bacterial 
ghost-based vaccine with suitable adjuvant material might trigger long-lasting 
immune responses and improved protection against pathogens. In particular, 
MontanideTM ISA 70 VG is a water-in-oil emulsion adjuvant containing a highly 
refined mannitol/oleic acid emulsifier (Dupuis et al., 2006). MontanideTM ISA 70 
VG has already been demonstrated to be safe and efficient in numerous poultry 
disease models (Aucouturier et al., 2006; Jang et al., 2010; Liu et al., 2011). 
In the present study we constructed the S. Gallinarum ghost carrying LTB 
protein and an animal study was designed to evaluate the efficacy of MontanideTM 
ISA 70 VG when combined with S. Gallinarum-LTB ghost in protecting against 
fowl typhoid infection. To assess the adjuvant effect, chickens were immunised 
with either S. Gallinarum-LTB ghosts combined with MontanideTM ISA 70 VG 
or S. Gallinarum-LTB ghosts alone. To assess the protective effect of vaccina-
tion, we challenged chickens with a lethal dose of wild-type S. Gallinarum. 
 
 
Materials and methods 
Bacterial strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Table 1. 
The S. Gallinarum bacteria with deleted aspartate β-semialdehyde dehydrogenase 
(asd) gene were grown at 37 °C in LB broth containing 50 µg/ml diaminopimelic 
acid (DAP). 
Generation of S. Gallinarum ghost carrying LTB protein 
The JOL1253 strain was transformed with plasmid pJHL187-LTB by 
means of electroporation and the resultant strain was named JOL1367. The bac-
terial ghost cells were generated from the JOL1367 strain as described previ-
ously (Jawale and Lee, 2014a). The induction of gene E-mediated bacteriolysis 
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was monitored by measuring the optical density at 600-nm wavelength (OD600) 
and the colony-forming units (CFU) of viable cells at different lysis time-points. 
The vector control (JOL1366) strain was constructed by transforming JOL1253 
with plasmid pMMP187. 
Table 1 
Bacterial strains, plasmids and primers utilised in this study 
Strain/plasmid Description Reference 
Bacterial strains   
JOL1253 Salmonella Gallinarum, asd gene knockout strain Chaudhari et al., 2012 
JOL420 Salmonella Gallinarum wild type Chaudhari et al., 2012 
JOL422 Salmonella Gallinarum wild type, challenge strain Chaudhari et al., 2012 
JOL1366 JOL1253 containing pJHL187 This study 
JOL1367 JOL1253 containing pJHL187-LTB This study 
Plasmids   
pJHL187 Asd+ p15A ori plasmid carrying ghost cassette Jawale and Lee, 2014a 
pJHL187-LTB pJHL187 containing eltB gene Jawale and Lee, 2014a 
Primers   
GAPDH-F 5’-AGAACATCATCCCAGCGTCC-3’ This study 
GAPDH-R 5’-CGGCAGGTCAGGTCAACA-3’  
IFN-γ-F 5’-CAAAGCCGCACATCAAACA-3’ This study 
IFN-γ-R 5’-TTTCACCTTCTTCACGCCATC-3’  
IL2-F 5-‘ATCTTTGGCTGTATTTCGGTAG-3’ This study 
IL2-R 5’-TGGGTCTCAGTTGGTGTGTAG-3’  
 
Confirmation of LTB protein production in the S. Gallinarum ghost 
The presence of LTB protein in the outer membrane of S. Gallinarum-LTB 
ghost envelopes was validated by Western blot analysis. Outer membrane protein 
fraction samples from S. Gallinarum-LTB ghosts and vector control strain ghost 
cells were prepared as described previously (Jawale and Lee, 2014a). Briefly, the 
S. Gallinarum-LTB ghost cells were resuspended in sterile PBS and subjected to 
sonication for 30 min. The sonicated suspension was centrifuged at 20,000 rpm 
for 30 min. The pellet was dissolved in Tris-Sarkosyl buffer (20 mM Tris con-
taining 1% sarkosyl, pH 8.6) and incubated on ice for 30 min. The suspension 
was centrifuged with 132,000 g for 1 h at 4 °C to obtain the supernatant contain-
ing the outer membrane protein fraction, and the samples were stored at –20 °C. 
A similar procedure was used to prepare outer membrane protein fractions of S. 
Gallinarum vector control ghost cells. Protein extracts of S. Gallinarum-LTB 
ghosts were heated at 95 °C for 5 min and then resolved by sodium dodecyl sul-
phate polyacrylamide gel electrophoresis (SDS-PAGE) on 15% gels. The re-
solved proteins were then electrophoretically transferred to polyvinylidene fluo-
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ride membranes (Millipore, Billerica, MA) for immunoblotting. The membranes 
were blocked overnight at 4 °C with 3% bovine serum albumin (BSA) in PBS 
with 0.01% Tween 20, and they were subsequently incubated with polyclonal 
anti-LTB rabbit serum and horseradish peroxidase- (HRP-) conjugated goat anti-
rabbit IgG antibodies. Immunoreactive bands were detected with chemilumines-
cent dye and the WEST-one Western blot detection system (iNtRON, Seongnam, 
South Korea). Signals were detected using the multi-wavelength illumination 
system on a Kodak Image Station 4000MM (Kodak, New Haven, CT, USA). 
Immunisation and challenge regimen 
The oil-adjuvanted ghost vaccine was prepared by emulsifying the S. Gal-
linarum-LTB ghost suspension with MontanideTM ISA 70 VG (Seppic, Puteaux, 
France) at a ratio of 30:70 (w/w). The final dose of the inactivated oil-emulsion 
S. Gallinarum-LTB ghost vaccine was 1 × 109 ghost cells per bird. All experi-
mental work involving animals was approved (CBU 2014-1-0038) by the Chon-
buk National University Animal Ethics Committee in accordance with the guide-
lines of the Korean Council on Animal Care. A total of 60 Salmonella-free fe-
male Brown Nick layer chickens were randomly divided into Groups A, B, and 
C (n = 20). All birds were housed in the same room and given ad libitum access 
to water and antibiotic-free feed. Chickens were intramuscularly primed at 5 
weeks of age and subsequently boosted at 8 weeks of age. Group A chickens 
were used as non-immunised controls and were injected intramuscularly with 
sterile phosphate buffered saline (PBS, pH 7.4). Group B chickens were primed 
and boosted with 0.3 mL of suspension containing 1 × 109 S. Gallinarum-LTB 
ghost cells. Group C chickens were primed and boosted with inactivated oil-
emulsion S. Gallinarum-LTB ghost vaccine. At 11 weeks of age, all chickens 
were orally challenged with 5 × 106 CFU of virulent S. Gallinarum (JOL422). 
Sample collection and humoral immune response 
Plasma samples were obtained by centrifuging the blood samples at 
13,000 rpm for 5 min. Indirect ELISA was performed with an outer membrane 
protein (OMP) fraction that was extracted from the wild-type S. Gallinarum 
strain JOL420. Evaluation of plasma IgG concentrations was performed as pre-
viously described using chicken IgG and IgA ELISA Quantitation Kits (Bethyl 
Laboratories, TX, USA) (Chaudhari et al., 2012). 
Antigen-specific lymphocyte proliferation assay 
The lymphocyte proliferation assay (LPA) was performed with soluble an-
tigens prepared from the wild-type JOL420 S. Gallinarum strain as previously 
described (Chaudhari et al., 2012). Briefly, a suspension of 5 × 105 viable pe-
ripheral blood mononuclear cells (PBMCs) was incubated in triplicate in wells of 
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96-well tissue culture plates with 50 μL of complete RPMI medium alone or con-
taining 4 μg/mL of soluble antigen at 40 °C in a humidified 5% CO2 atmosphere 
for 72 h. The proliferation of stimulated lymphocytes was measured and the 
mean stimulation index (SI) was determined as described previously (Chaudhari 
et al., 2012). 
Quantitative analysis of cytokine mRNA by real-time PCR 
At 3 weeks after booster vaccination, the in vitro stimulated PBMCs from 
immunised and non-immunised chickens were assayed to determine cytokine 
gene expression. Briefly, 1 × 106 viable PBMCs were incubated in 6-well tissue 
culture plates with 4 μg/mL of soluble antigen extracted from JOL420. The 
plates were incubated at 40 °C in a humidified 5% CO2 atmosphere for 72 h. To-
tal RNA from cultured cells was treated with DNAse I and converted into cDNA 
using a high-capacity cDNA reverse transcription kit (Applied Biosystems, USA). 
The primers used for quantification of cytokine mRNA are listed in Table 1. 
Relative quantification of cytokines IFN-γ and IL-2 was performed using the 
comparative Ct method. The endogenous control GAPDH was used to normalise 
expression of target cytokines. 
Protection against virulent efficacy challenge 
We challenged 20 chickens from each group with JOL422. Chickens from 
all groups were observed for fowl typhoid symptoms for 2 weeks post challenge. 
The birds that died during the post-challenge observation period were necropsied 
immediately, and survivors were euthanised 14 days post challenge, with necrop-
sies performed at that time. Gross hepatic and splenic lesions were scored as 0, 1, 
2 or 3, using a scoring system described previously (Chaudhari et al., 2012). De-
tection of the challenge strain in the liver and spleen tissues was carried out as 
described previously (Nandre and Lee, 2014). 
Statistical analysis 
Statistical analysis was performed with SPSS 16.0 (SPSS Inc., Chicago, IL, 
USA). All results are expressed as the mean ± standard deviation of the mean (SD) 
unless otherwise specified. The data regarding plasma IgG concentration, SI, cy-
tokine gene expression and organ lesion score were analysed using one-way 
ANOVA with Bonferroni correction. In addition, the number of birds positive for 
the challenge strain and bird mortality were analysed by Chi-square test. Differ-
ences were considered to be statistically significant when P values were ≤ 0.05. 
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Results 
Production and characterisation of the S. Gallinarum-LTB ghost 
The OD of the JOL1367 culture decreased during the first few hours after 
induction of gene E expression as a function of cell lysis and remained almost 
constant until the ghost cells were harvested. The CFU count decreased rapidly 
after the temperature was increased, and no viable cells were detected at 48 h 
post induction. The eltB gene was cloned in the antigen delivery cassette of the 
plasmid pMMP187-LTB under the control of λpR promoter. The presence of the 
LTB protein was detected by Western blot assay. The fusion protein comprising 
OmpA-TM and LTB is approximately 26.9 kDa in size, which was observed in 
the outer membrane protein preparation extracted from S. Gallinarum-LTB ghost 
cells (Fig. 1). No corresponding band of similar size was detected in wells loaded 
with the outer membrane protein preparation extracted from ghosts of the vector 
control JOL1366 strain. 
 
Fig. 1. Confirmation of Escherichia coli heat-labile enterotoxin B subunit (LTB) protein produc-
tion in Salmonella Gallinarum LTB-ghosts by Western blot analysis. Salmonella Gallinarum ghost 
prepared from the vector control strain (JOL1366) was used as negative control. Lane M, size 
marker; lane 1, S. Gallinarum-LTB ghost showing the 26.9-kDa OmpA-LTB fusion protein band 
(indicated by arrowhead); lane 2, S. Gallinarum-ghost prepared from the vector control strain 
Development of systemic antibody response after vaccination 
The mean plasma IgG titres in Groups B and C were significantly elevated 
(1.64- and 3.06-fold, respectively), compared to the non-immunised control 
Group A in the second week post immunisation (P < 0.05) (Fig. 2). The booster 
dose of immunisation enhanced the significant induction of plasma IgG titres in 
both immunised groups. Comparison of IgG titres between immunised groups 
revealed that the titres of Group C chickens were significantly higher than those 
of Group B chickens in the second, third, fifth and sixth weeks after prime im-
munisation (P < 0.05) (Fig. 2). 
Lymphocyte proliferation assay 
The PBMCs of immunised Group B and C chickens exhibited significantly 
greater proliferation upon antigen-specific stimulation than those of non-immunised 
Group A chickens (P ≤ 0.05) (Fig. 3). Stimulation index (SI) values (mean ± SD) 
of Groups A, B and C were 1.2 ± 0.12, 2.08 ± 0.58 and 2.47 ± 0.56, respectively. 
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Fig. 2. Systemic antibody response. Antigen-specific plasma IgG responses in the non-immunised 
control group (A), the group immunised with S. Gallinarum-LTB ghost (B) and the group immu-
nised with S. Gallinarum-LTB ghost plus MontanideTM ISA 70 VG (C) were determined in the 
weeks after immunisation. Arrowhead indicates the time-point for booster immunisation. The 
plasma IgG titres of each analysed sample are indicated by a group-specific symbol. Lowercase let-
ters indicate significant differences in the IgG values of the immunised groups compared to those 
of the control group: b, immunised Group B chickens compared to the control group; c, immunised 
Group C chickens compared to the control group. Significant differences between the vaccinated 
groups are denoted by asterisks 
 
Fig. 3. Lymphocyte proliferative response: S. Gallinarum antigen-specific lymphocyte proliferative 
responses in the immunised and non-immunised chickens in the 3rd week after booster vaccina-
tion. The asterisks indicate significant differences between the stimulation index (SI) values of the 
immunised and non-immunised groups. Groups A, B, and C refer to Table 1 and Fig. 2 
Cytokine gene expression after in vitro antigenic stimulation 
The mRNA levels of IFN-γ and IL-2 were significantly increased in the 
total RNA isolated from stimulated PBMCs of immunised Group B and C chick-
ens compared those from non-immunised chickens (P ≤ 0.05) (Fig. 4). These 
data indicate the immunostimulatory effects of vaccination with bacterial ghosts 
that result in the induction of Th1 cytokine response, which is involved in protec-
tive immunity against intracellular bacterial pathogens. 
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Protective efficacy after wild-type challenge 
On the 5th day after challenge with the virulent strain, 90% of the control 
Group A chickens started to show distinctive clinical signs of fowl typhoid such 
as anorexia, depression and diarrhoea. The clinical signs of fowl typhoid were 
also observed in 50% of Group B chickens and 20% of Group C chickens. At 14 
days post challenge, the immunised Groups B and C exhibited 65% (P = 0.01) 
and 80% (P = 0.001) survival, respectively, compared with the 20% survival 
found in the control Group A. The immunised and challenged Group B and C 
chickens showed significantly lower gross lesion scores of liver and splenic tis-
sue (P ≤ 0.05) (Table 2). Bacterial recovery results indicated that a significantly 
lower number of birds in the immunised Groups B and C exhibited challenge in-
fection compared to the control group (P ≤ 0.05) (Table 2). Among the immu-
nised groups, Group C chickens were better protected against challenge. 
Table 2 
Survival rate, gross lesion score and bacterial recovery after virulent challenge 
Gross lesion scoreb 
Group# N Survivala (%) n/N 
Liver Spleen 
A 20 4 (20%) 20/20 2.7 ± 0.73c 2.65 ± 0.74 
B 20 13 (65%)** 13/20** 1.6 ± 1.5* 1.35 ± 1.42** 
C 20 16 (80%)*** 13/20** 1.25 ± 1.44** 1.1 ± 1.16*** 
#Groups: A, non-immunised control; B, immunised with S. Gallinarum-LTB ghost; C, immunised 
with S. Gallinarum-LTB ghost plus MontanideTM ISA 70 VG; N = number of birds used in each 
group; n/N = number of S. Gallinarum challenge strain positive birds per total number of birds; 
anumber of birds surviving after virulent S. Gallinarum challenge; bgross lesions scores observed 
after necropsy of challenged birds; cgroup lesion score (mean ± SD). All values were considered to 
be significant if P ≤ 0.05 or 0.01. *P < 0.05, **P < 0.01, ***P < 0.001 vs. the non-immunised Group A 
 
 
Discussion 
Adequate balance between safety and immunogenicity is crucial for de-
signing effective vaccines against fowl typhoid. Live attenuated vaccines are fre-
quently used for effective protection against fowl typhoid. However, safety is a 
major concern when using live vaccines due to their residual virulence (Kwon 
and Cho, 2011) and long persistence in the internal organs of immunised chick-
ens, which may cause adverse effects in immunised hosts and contaminate the 
environment via shedding of live attenuated strains through faeces (Nandre and 
Lee, 2014). Thus, we have directed efforts towards the development of geneti-
cally inactivated bacterial ghost-based vaccines. 
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Gene E-mediated lysis of a mid-logarithmic phase-grown culture of 
JOL1367 was induced with no further increase in OD600, and the number of vi-
able cells decreased dramatically. Protein E acts by inhibiting peptidoglycan syn-
thesis and thereby prevents cell wall synthesis, which accounts for the reduced 
OD and number of viable cells during the lysis procedure (Bernhardt et al., 
2000). In the present study we made an attempt to incorporate the LTB molecule 
in the outer membrane portion of S. Gallinarum ghost cells. The ability of LTB 
to bind to the GM1 receptor of eukaryotic cells also facilitates the increased up-
take of antigens coupled with LTB by antigen-presenting cells (Freytag and 
Clements, 2005). The shifting of JOL1367 cultures from 28 °C to 42 °C also 
triggered λpR-driven expression of eltB and the presence of LTB protein in the 
ghost preparation was confirmed by Western blot (Fig. 1). The idea behind the 
utilisation of MontanideTM ISA 70 VG in combination with bacterial ghost was 
to prolong the presence of the bacterial ghost antigens in the immunised birds. 
The mechanism of action of MontanideTM ISA adjuvant includes the formation 
of a depot at the injection site, which enables the slow release of the antigen, and 
formulated antigens are concentrated and protected against degradation while 
phagocytosis is stimulated (Levast et al., 2014). 
A number of studies have demonstrated that the expression of acquired re-
sistance to fowl typhoid depends upon the combined humoral and cell-mediated 
immune response of the infected host (Rana and Kulshreshtha, 2006; Park et al., 
2010; Matsuda et al., 2011). In the present study, we observed a significant in-
duction of systemic IgG responses in the immunised groups, especially in chick-
ens immunised with a combination of ghost cells with MontanideTM ISA 70 VG 
(Fig. 2). MontanideTM ISA series adjuvants are known to enhance systemic anti-
body responses against combined antigens (Jang et al., 2010). The systemic anti-
bodies clear Salmonella from the blood, and also promote phagocytosis of Sal-
monella via opsonisation (Mastroeni et al., 2011). Anti-Salmonella IgG plays a 
primary role during the early clearance phase of the infection, but once the or-
ganisms become established in an intracellular environment within the liver and 
spleen, their subsequent elimination depends upon cell-mediated immune re-
sponse (Rana and Kulshreshtha, 2006; Lee et al., 2007). In the present study, 
significant cell-mediated immune responses were shown by LPA in both immu-
nised groups (Fig. 3). The present study shows that Th1 cytokines are produced 
in high numbers by vaccinated chickens. The levels of IL-2 and IFN-γ cytokine 
mRNA produced in vitro by antigen-stimulated PBMCs from the vaccinated 
chickens were significantly higher than those produced by cells from chickens of 
the non-vaccinated control group (Fig. 4). Without a doubt, the Th1-cell immu-
nity developed by the vaccinated chickens fits with the protection conferred 
against fowl typhoid (Chappell et al., 2009; Park et al., 2010). 
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Fig. 4. Cytokine profile of in vitro stimulated PBMC cultures. Groups A, B, and C refer to Table 2 
and Fig. 2. The significant differences in cytokine expression between the control and immunised 
groups are indicated by asterisks (*indicates P ≤ 0.05) 
 
In the current experimental design we used 5 × 106 CFU of challenge strain 
per bird administered via an oral route. In spite of this large challenge strain dose, 
both immunised groups showed significant protection, evidenced by significantly 
higher survival rates and lower gross lesions in the liver and spleen after virulent 
S. Gallinarum challenge infection. The challenge strain remained in the liver and 
spleen of some of the vaccinated chickens on the 14th day post challenge, but it 
is likely to be cleared via acquired immunity (Wigley et al., 2005). Among the 
immunised groups, the chickens vaccinated with the ghost plus Montanide 
ISATM 70 VG showed higher survival rates compared to those from chickens 
vaccinated with the ghost alone. Until recently, very few efforts have been di-
rected toward the production of safe and immunogenic inactivated vaccines 
against fowl typhoid (Bouzoubaa et al., 1987; Bouzoubaa et al., 1989; Chaudhari 
et al., 2012; Jawale et al., 2014; Jawale and Lee, 2014b). The results of the cur-
rent study highlight further progress in the development of inactivated S. Gallina-
rum vaccines. It stands very clear that the vaccination of chickens with a combi-
nation of S. Gallinarum-LTB ghost with Montanide ISATM 70 VG may be a use-
ful and effective tool to prevent fowl typhoid. 
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